Document Detail


Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.
MedLine Citation:
PMID:  20875798     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Synaptic pathology occurs early in Alzheimer's disease (AD) development, and cerebrospinal fluid biomarkers for synaptic damage may be altered early in the disease process. In the present study we examined cerebrospinal fluid levels of the postsynaptic protein neurogranin in patients with mild cognitive impairment (MCI) or AD and controls. The low neurogranin level in cerebrospinal fluid required enrichment by immunoprecipitation prior to mass spectrometric identification and semi-quantitative immunoblot analysis. Relative quantification revealed a significant increase of neurogranin in the AD group compared with controls, while the MCI group was not statistically different from either controls or the AD group. The concentrations of the AD biomarkers T-tau, P-tau(181) and Aβ(42) were significantly changed in the control and MCI groups compared with the AD group, but no significant differences were found between the MCI group and controls for the three biomarkers. Nevertheless, a trend towards increasing levels of neurogranin, T-tau and P-tau(181) was found in cerebrospinal fluid from MCI patients compared with controls. The elevated neurogranin levels in the MCI and AD groups might reflect synaptic degeneration. These results together suggest that cerebrospinal fluid neurogranin might be valuable together with the established AD biomarkers in the early diagnosis of AD and warrants further studies to determine the diagnostic value of neurogranin.
Authors:
Annika Thorsell; Maria Bjerke; Johan Gobom; Eva Brunhage; Eugeen Vanmechelen; Niels Andreasen; Oskar Hansson; Lennart Minthon; Henrik Zetterberg; Kaj Blennow
Related Documents :
17827418 - Circulating interleukin-15 in dementia disorders.
16526588 - The corpus callosum in pick's disease, alzheimer's disease, and amyotrophic lateral scl...
2468498 - Immunoreactive substance p and somatostatin in the cerebrospinal fluid of senile parkin...
7732768 - Autonomic dysfunction in alzheimer's disease.
19968328 - Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic reson...
18705548 - Novoseven use in a non-cardiac pediatric ecmo patient with uncontrolled bleeding.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-25
Journal Detail:
Title:  Brain research     Volume:  1362     ISSN:  1872-6240     ISO Abbreviation:  Brain Res.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0045503     Medline TA:  Brain Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  13-22     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier B.V. All rights reserved.
Affiliation:
Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden. annika.thorsell@neuro.gu.se
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  TRIM39 and RNF39 are associated with Behçet's disease independently of HLA-B?51 and -A?26.
Next Document:  The treatment of anxiety symptoms in youth with high-functioning autism spectrum disorders: Developm...